Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pere Gines

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Therapeutic Advances in Neurological Disorders|November 2, 2017
Liver injury and glatiramer acetate, an uncommon association: case report and literature reviewJavier Almeida, Nuria Solà-Valls, Elisa Pose, et al.
Journal of Hepatology|July 4, 2012
Acute-on chronic liver failureRajiv Jalan, Pere Gines, Jody C Olson, et al.
Journal of Hepatology|March 15, 2013
Reply to: "Acute-on-chronic liver failure - its definition remains unclear"Rajiv Jalan, Pere Gines, Jody C Olson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 27, 2009
Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same areaXavier Xiol, Pere Gines, Lluis Castells, et al.
Journal of Hepatology|August 24, 2024
Variation in intention-to-treat survival by MELD subtypes: All models created for end-stage liver disease are not equalCraig Rosenstengle, Marina Serper, Sumeet K Asrani, et al.
Gastroenterology|May 24, 2014
Toward an improved definition of acute-on-chronic liver failureRajiv Jalan, Cihan Yurdaydin, Jasmohan S Bajaj, et al.
BMJ Open|February 14, 2024
Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trialNikolaj Torp, Mads Israelsen, Minneke Coenraad, et al.
Journal of Hepatology|November 1, 2015
Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failureRajeshwar P Mookerjee, Marco Pavesi, Karen Louise Thomsen, et al.
Hepatology (Baltimore, Md.)|January 12, 2026
Liverrisk score (LRS) predicts long-term liver-related outcomes in a cohort of veterans without evidence of liver diseaseRuben Hernaez, Yan Liu, Miquel Serra-Burriel, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites ClubKevin P Moore, Florence Wong, Pere Gines, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Neurological Disorders|November 2, 2017
Liver injury and glatiramer acetate, an uncommon association: case report and literature reviewJavier Almeida, Nuria Solà-Valls, Elisa Pose, et al.
Journal of Hepatology|July 4, 2012
Acute-on chronic liver failureRajiv Jalan, Pere Gines, Jody C Olson, et al.
Journal of Hepatology|March 15, 2013
Reply to: "Acute-on-chronic liver failure - its definition remains unclear"Rajiv Jalan, Pere Gines, Jody C Olson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 27, 2009
Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same areaXavier Xiol, Pere Gines, Lluis Castells, et al.
Journal of Hepatology|August 24, 2024
Variation in intention-to-treat survival by MELD subtypes: All models created for end-stage liver disease are not equalCraig Rosenstengle, Marina Serper, Sumeet K Asrani, et al.
Gastroenterology|May 24, 2014
Toward an improved definition of acute-on-chronic liver failureRajiv Jalan, Cihan Yurdaydin, Jasmohan S Bajaj, et al.
BMJ Open|February 14, 2024
Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trialNikolaj Torp, Mads Israelsen, Minneke Coenraad, et al.
Journal of Hepatology|November 1, 2015
Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failureRajeshwar P Mookerjee, Marco Pavesi, Karen Louise Thomsen, et al.
Hepatology (Baltimore, Md.)|January 12, 2026
Liverrisk score (LRS) predicts long-term liver-related outcomes in a cohort of veterans without evidence of liver diseaseRuben Hernaez, Yan Liu, Miquel Serra-Burriel, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites ClubKevin P Moore, Florence Wong, Pere Gines, et al.
Pageof 5